Découvrez le nouveau Chem-Impex : là où l'innovation commence par une liaison.

Catalog Number:
37731
CAS Number:
282526-98-1
Cétilistat
Purity:
≥ 98 % (HPLC)
Synonym(s):
2-Hexadécyloxy-6-méthyl-4 H -3,1-benzoxazine-4-one
Documents
$102.85 /1G
Taille
Request Bulk Quote
Informations sur le produit

Cetilistat is a potent pharmaceutical compound recognized for its role as a weight management agent. This innovative drug functions by inhibiting pancreatic lipase, an enzyme crucial for the digestion of dietary fats. By reducing fat absorption in the gastrointestinal tract, Cetilistat aids in weight loss and is particularly beneficial for individuals struggling with obesity or metabolic disorders. Its effectiveness has been demonstrated in various clinical studies, making it a valuable option for healthcare professionals and researchers focused on obesity treatment and management.

In addition to its primary application in weight management, Cetilistat has garnered interest for its potential in metabolic syndrome research, offering insights into lipid metabolism and energy balance. Its unique mechanism of action sets it apart from other weight loss agents, providing a targeted approach to fat absorption. As a result, Cetilistat is not only a significant compound for pharmaceutical development but also a promising candidate for further research in obesity and metabolic health.

Numéro CAS 
282526-98-1
Formule moléculaire
C 25 H 393
Poids moléculaire 
401.59
Point de fusion 
72 - 76 °C
Informations générales
Numéro CAS 
282526-98-1
Formule moléculaire
C 25 H 393
Poids moléculaire 
401.59
Point de fusion 
72 - 76 °C
Propriétés
Informations complémentaires sur la propriété à venir prochainement !
-
Sécurité et réglementation
Matières dangereuses
-
Antibiotique
-
Réglementé par la DEA
Non
Avertissements 
-
Applications

Cetilistat is widely utilized in research focused on:

  • Weight Management: Cetilistat is primarily used as an anti-obesity drug, helping individuals manage weight by inhibiting fat absorption in the intestines. This application is particularly beneficial in the health and wellness industry, where obesity is a growing concern.
  • Diabetes Control: Research indicates that cetilistat may aid in improving glycemic control in patients with type 2 diabetes. This makes it valuable in the pharmaceutical industry, especially for developing treatments that address both obesity and diabetes simultaneously.
  • Clinical Trials: The compound is frequently involved in clinical trials aimed at assessing its efficacy and safety for weight loss. This is crucial for researchers and healthcare professionals looking to provide evidence-based treatments.
  • Combination Therapies: Cetilistat is explored in combination with other medications to enhance weight loss results. This application is significant for healthcare providers seeking comprehensive treatment plans for patients struggling with obesity.
  • Research on Metabolic Disorders: The chemical is also studied for its potential effects on metabolic disorders, making it relevant in academic and clinical research settings focused on understanding and treating these conditions.

Citations